Guardian Approval Should Give Medtronic Sizable Lead In CGMS Market
This article was originally published in The Gray Sheet
Executive Summary
FDA approval of Medtronic's Guardian continuous glucose monitoring system gives the firm a headstart on primary competitor TheraSense's FreeStyle Navigator CGMS